| | | | | | | | | | | | | | NLN Clinical Focus Group – Clinical Practice Barriers 📅 Thursday, April 9 | ⏰ 7:00 PM ET | 📍 Online 🎟️ NLN Members Only | Registration required Join us for the upcoming Clinical Focus Group on Clinical Practice Barriers, facilitated by Bethany Beckwith, OTR/L, CScD, CLT-LANA. This interactive session creates space for open discussion around the everyday challenges clinicians face in practice. Together, participants will explore common barriers to care delivery, strategies for overcoming obstacles, and approaches that may strengthen treatment options and improve patient outcomes. Bring your questions, share real-world experiences, and connect with peers in a collaborative conversation designed to deepen understanding and support clinical growth. ✅ Open to all levels of experience 📝 Submit questions or discussion topics ahead of time: continuingeducation@lymphnet.org | | | | | | | | | | | | | | | | | | | | | | | | NLN Networking Meeting in New York 📅 Wednesday, April 8 | ⏰ 6:00 PM | 📍 Binghamton, NY Join local healthcare professionals for an in-person evening of connection, collaboration, and community building in lymphatic care. This free networking meeting is open to members and non-members across all healthcare disciplines. | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Thursday, April 16 12:00 pm ET | | | | | | | | | | | Friday, April 17 5:30 pm ET | | | | | | | | | | | Saturday, April 18 10:00 am - 1:00 pm New Jersey | | | | | | | | | | | | | | | | | | | | | | | | | Thank You to Our Gold Sponsors | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Have questions about lymphedema or need help finding treatment? Contact the NLN Patient Support Team at 800-541-259 or patientsupport@lymphnet.org for guidance, resources, and support. National Lymphedema Network 2229 Bridge Avenue #667 Point Pleasant, NJ 08742 (800) 541-3259 If you would like to unsubscribe: please click here Copyright © 2026 National Lymphedema Network, All rights reserved. | | | | | | | | | | | | | | | | | | | |